CONSTANCE LACKNER: Open Payments
NPI 1922068022 · ROGERSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,413 in 81 payments from 11 companies in 2025. Trend: 2023 $351 · 2024 $645 · 2025 $1,413
Food & beverage: $1,413
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 14 | $226 |
| Otsuka America Pharmaceutical, Inc. | 12 | $211 |
| Vanda Pharmaceuticals Inc. | 13 | $209 |
| Janssen Pharmaceuticals, Inc | 15 | $191 |
| Teva Pharmaceuticals USA, Inc. | 7 | $179 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $112 |
| Alkermes, Inc. | 6 | $99 |
| Lundbeck LLC | 4 | $71 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
| Axsome Therapeutics, Inc. | 2 | $30 |
Products named: INGREZZA, HETLIOZ, INVEGA SUSTENNA, UZEDY, ABILIFY MAINTENA, CAPLYTA, REXULTI, ARISTADA.
Industry payments across TN — which companies pay providers there.
